Inventor · Saffron Walden, GB

Mark Smith

47Patents
11h-index
58Co-inventors
78Inventor score

Filing activity: Dec 17, 1999 → Sep 30, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US7541444B2 Modified nucleotides Emerging Cross-Sectional Technologies 207 Expired
US6846810B2 Antiviral nucleoside derivatives Human Necessities 118 Expired
US9889422B2 Methods of localizing nucleic acids to arrays Emerging Cross-Sectional Technologies 85 Active
US7771973B2 Modified nucleotides Emerging Cross-Sectional Technologies 80 Active
US8071739B2 Modified nucleotides Emerging Cross-Sectional Technologies 59 Active
US8563477B2 Modified molecular arrays Emerging Cross-Sectional Technologies 53 Active
US8597881B2 Modified nucleotides Emerging Cross-Sectional Technologies 46 Active
US9121060B2 Modified nucleotides Emerging Cross-Sectional Technologies 40 Active
US7378402B2 Anti-viral nucleosides Chemistry; Metallurgy 38 Expired
US9388464B2 Modified nucleotides Emerging Cross-Sectional Technologies 35 Active
US6458851B1 Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications Human Necessities 13 Expired
US10513731B2 Modified nucleotides Emerging Cross-Sectional Technologies 11 Active
US8969258B2 Methods of localizing nucleic acids to arrays Emerging Cross-Sectional Technologies 8 Active
US9295729B2 Reversible covalent linkage of functional molecules Emerging Cross-Sectional Technologies 7 Active
US10525437B2 Methods and compositions of localizing nucleic acids to arrays Emerging Cross-Sectional Technologies 5 Active
US9376710B2 Methods of localizing nucleic acids to arrays Emerging Cross-Sectional Technologies 4 Active
US9926309B2 Pi-kinase inhibitors with anti-infective activity Chemistry; Metallurgy 4 Active
US6462091B1 Combinations of cholesteryl ester transfer protein inhibitors and HMG coA reductase inhibitors for cardiovascular indications Human Necessities 4 Expired
US9370569B2 4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication Chemistry; Metallurgy 4 Active
US11654411B2 Methods and compositions of localizing nucleic acids to arrays Emerging Cross-Sectional Technologies 3 Active
US10092649B2 4′-difluoromethyl substituted nucleoside derivatives as inhibitors of influenza RNA replication Chemistry; Metallurgy 3 Active
US10953379B2 Methods and compositions of localizing nucleic acids to arrays Emerging Cross-Sectional Technologies 3 Active
US9895442B2 4′-fluoro-2′-methyl substituted nucleoside derivatives as inhibitors of HCV RNA replication Chemistry; Metallurgy 2 Active
US8921388B2 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease Chemistry; Metallurgy 2 Active
US11091472B2 PI-kinase inhibitors with anti-infective activity Chemistry; Metallurgy 2 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.